1)Slow-releasing fluoride缓释氟
英文短句/例句
1.Combined Fluorouracil or Cisplatin Sustained Release Seed with ~(125)I Particle to Treat Lung Cancer缓释氟尿嘧啶与缓释顺铂粒子联合~(125)I粒子治疗肺癌
2.Clinical Observation of Regional Chemotherapy on Breast Cancer Patients with Sustained-release Fluorouracil for Implant during Operation;乳腺癌术中植入缓释氟尿嘧啶的临床观察
3.The Clinical Application of ~(125)Ⅰ Seeds Combined with Fluorouracil Implants for Old Patients with Lung Cancer碘-125（~（125）Ⅰ）粒子联合缓释氟尿嘧啶在老年肺癌患者中的应用
4.Clinical Observation of Using Fluorouracil Sustained-release Implants during the Liver Cancer Operation肝癌切除术中植入缓释氟尿嘧啶剂的近期临床观察
5.The implantation of ~(125)Ⅰseeds combined with fluoroiracil implants for old patients with lung cancerCT导向下~(125)Ⅰ粒子联合缓释氟尿嘧啶治疗老年肺癌
6.Clinical study of intraperitoneal interstitial implant with sustained release fluorouracil during operation for advanced colorectal cancer结直肠癌术中腹腔植入缓释氟尿嘧啶的临床研究
7.Nursing care for elderly lung cancer patients treated with CT-guided permanent interstitial co-implantation of ~(125)I seeds and slow-released fluorouracil~(125)I粒子联合缓释氟尿嘧啶治疗老年肺癌的护理
8.Studies on the Sustained-Release Tablets and Pellets Capsules for Levofloxacin Aspartate;门冬氨酸左氧氟沙星缓释片和缓释微丸胶囊的研究
9.Experimental Study on Anticariogenic Effect of a New Type Slow Fluoride Orthodontic Bonding Adhesive新型氟缓释釉牙质粘接剂防龋齿实验研究
10.Experimental Research on Sustained-released Intraperitoneal Chemotherapy with 5-fluorouracil;5-氟尿嘧啶腹腔内缓释化疗的实验研究
11.Preparation and Study of Dipfluzine Intragastric Floating and Residence Sustained-release Tablet;双苯氟嗪胃内滞留漂浮型缓释片的研制
12.Analysis of the Efficacy of Radiotherapy and 5-FU Slow Release Particles in Treating Hepatic Carcinoma氟尿嘧啶缓释剂联合放射治疗肝癌的疗效
13.Security of 5-fluorouracil sustained-release reagent under orthoptic endoscope内镜直视下5-氟尿嘧啶缓释剂的安全性
14.Detecting the Dynamic Releasing of Ornidazole and Pefloxacinmesylate Sustained-release Periodontal Suppository in Vitro and Vivo;奥硝唑甲磺酸培氟沙星缓释牙栓体内外释放度的测定
15.Preparation and In Vitro Release Behavior of 5-Fluorouracil Loaded Sustained Release Microspheres by S/O/W MethodS/O/W法制备氟尿嘧啶缓释微球及其体外释药行为考察
16.Study of Carriers PEG-PCL-PEG Hydrogel Encapsulated Fluorouracil in Mice with Malignant Ascites;5-氟尿嘧啶水凝胶药物缓释体系治疗恶性腹腔积液的实验研究
17.Toxicological Experiment Study of Compound Ornidazole and Pefloxacinmesylat Sustained-release Periodontal Suppository;复方奥硝唑甲磺酸培氟沙星缓释牙栓毒理学安全性试验研究
18.Experimental Study of Pharmacodynamics of Compound Ornidazole and Pefloxacinmesylate Sustained-release Gum Suppository;复方奥硝唑甲磺酸培氟沙星缓释牙栓的药效学实验研究
相关短句/例句
sustained-release fluorouracil缓释氟尿嘧啶
1.Objective To explore the nursing method of intraperitoneal interstitialimplant with sustained-release fluorouracil during operation for advanced gastroenteric carcinoma to prevent the local recurrence of advanced gastroenteric carcinoma after operation.目的探讨胃肠道恶性肿瘤术中腹腔植入缓释氟尿嘧啶的护理方法,寻找预防胃肠道恶性肿瘤局部复发转移的新途径。
3)Flurbiprofen Sustained Release Tablets氟比洛芬缓释片
4)sustained release 5-fluorouracil缓释5-氟尿嘧啶
1.Objective: To investigate the significance of lymph node dissection guided by activate carbon and evaluate the safety of intraperitoneal chemotherapy with sustained release 5-fluorouracil during operation in advanced gastric cancer.目的:探讨胃癌手术中应用活性炭指导淋巴结清扫的意义,评价缓释5-氟尿嘧啶腹腔化疗的安全性。
5)sustained-release 5-fluorouracil氟尿嘧啶缓释剂
1.Intraoperative intraperitoneal chemotherapy with sustained-release 5-fluorouracil for treatment of locally advanced colon cancer术中局部使用氟尿嘧啶缓释剂治疗局部进展期结肠癌
6)Fluvastatin sodium extended-release tablets氟伐他汀钠缓释片
延伸阅读
氟比洛芬缓释片药物名称：氟比洛芬缓释片英文名：Flurbiprofen Sustained Release Tablets汉语拼音：主要成分：本品主要成分是氟比洛芬性状：本品为白色或类白色片。药理作用：本品为芳基丙酸类非甾体抗炎药，可能主要通过抑制前列腺素的合成而产生镇痛、抗炎、解热作用。药代动力学：本品口服200mg后吸收良好，血药浓度达峰时间约为5.33±2.42小时，血浆蛋白结合率为90％，消除半衰期约为5.7小时，本品主要经尿排泄。适应症：适用于类风湿性关节炎、骨关节炎、强直性脊椎炎等，也可用于软组织病，如扭伤及劳损，以及轻度至中度疼痛，如痛经和手术后疼痛、牙痛等。用法与用量：成人推荐剂量为每日0.2g，宜于晚上饭后服用。或遵医嘱。不良反应：较常见的不良反应是胃肠道系统反应，如消化不良、腹泻、腹痛、恶心、便秘、胃肠道出血、腹胀、呕吐、肝酶升高等。偶见中枢神经系统反应，如头痛、嗜睡等，以及其他系统反应，如皮疹、视力变化、头晕等等。禁忌症：1．对本品过敏者禁用。 2．服用本品、阿司匹林或其他非甾体抗炎药曾引起哮喘、鼻炎、荨麻诊或其他过敏性反应的患者禁用。 3．活动性消化道溃疡患者禁用。 4．儿童禁用本品。注意事项：1．有胃肠溃疡病患者慎用。 2．有支气管哮喘病史患者或因服用其它非甾体抗炎药曾发生支气管痉挛之病人应慎用。 3．孕妇和哺乳期妇女慎用。 4．心、肝、肾功能不全及高血压，血友病患者慎用。 5．类风湿性关节炎常可观察到贫血，故长期用药时应定期检查血象及肝、肾功能。 6．据报道本品可以引起视力变化，故有眼病的患者应慎用并进行眼科检查。 7．本品可以抑制血小板凝集，延长出血时间，故出血时间延长时患者应慎用。规格：0.2g。贮藏：遮光、密封保存。有效期：暂定二年。处方药：
